Skip to main content
. Author manuscript; available in PMC: 2019 Apr 1.
Published in final edited form as: J Asthma. 2017 Jul 11;55(4):416–423. doi: 10.1080/02770903.2017.1339244

Table 2.

Change in proportion of subjects with a prescription, all subjects and blacks only, 2004–2006.

TexKat
 LA - Nondisaster
 LA - Disaster
 TX
Population /
Prescription Type		 Changea
(SD)		 Changea
(SD)		 Differenceb
(p-value)		 Changea
(SD)		 Differenceb
(SD)		 Changea
(Std Dev)		 Differenceb
(SD)
All
 Controller −0.088 0.003 −0.091 −0.005 −0.083 0.056 −0.144
(0.018) (0.003) (0.0000) (0.003) (0.0000) (0.002) (0.0000)
 Quick-Relief −0.084 −0.021 −0.064 −0.009 −0.075 −0.048 −0.036
(0.020) (0.003) (0.0005) (0.003) (0.0001) (0.002) (0.0652)
 N 1,151 45,982 62,317 100,580
Blacks only
 Controller −0.097 −0.003 −0.094 −0.027 −0.070 0.041 −0.138
(0.019) (0.004) (0.0000) (0.003) (0.0004) (0.005) (0.0000)
 Quick-Relief −0.087 −0.023 −0.064 −0.034 −0.053 −0.035 −0.052
(0.021) (0.004) (0.0009) (0.003) (0.0069) (0.005) (0.0109)
 N 1,070 24,643 34,137 13,651
a

The top number in each cell is the change in sample proportion from 2004–2006 and the bottom is the standard deviation.

b

The top number in each cell is the difference between the TexKat change and the change for that control group, while the bottom number is the p-value from a t-test of the equivalence of the TexKat change and the change for that control group.